Barr Laboratories

61 articles about Barr Laboratories

• Unity Management Group Receives Large Purchase Order for their AIM Instrumentation Package From Barr Laboratories, Subdivision of Teva Pharmaceutical Industries Limited (NASDAQ: TEVA)

  10/12/2011

• Kentucky Reaches $10M Settlement With TEVA Pharmaceuticals USA, IVAX Pharmaceuticals, Inc., Barr Laboratories, Sicor Inc., IVAX Corporation and Teva Women's Health, Inc. (Formerly Known as Duramed Pharmaceuticals, Inc.)

  8/16/2010

• Celgene Says Barr Laboratories Withdrew Generic Thalomid Filing; Dismisses Suit Against Barr

  5/27/2010

• Barr Laboratories Issues a Voluntary Nationwide Recall of Dextroamphetamine/Amphetamine 20mg Tablets

  8/14/2009

• Shire plc Files Lawsuit Against Barr Laboratories for Infringement of FOSRENOL(R) (Lanthanum Carbonate) Patents

  3/17/2009

• Barr Laboratories, Mylan Inc. Plan Generics of Shire plc's Fosrenol Drug

  2/9/2009

• Teva Pharmaceutical Industries Limited Completes Acquisition of Barr Laboratories

  12/23/2008

• Teva Pharmaceutical Industries Limited, Barr Laboratories Say FTC Seeks More Merger Information

  9/4/2008

• Barr Laboratories Announces Favorable Ruling in Razadyne(R) Patent Challenge

  8/28/2008

• Christine Mundkur Named CEO of Barr Laboratories; Fred Wilkinson Named CEO of Duramed Pharmaceuticals, Inc.

  3/28/2008

• Encysive Pharmaceuticals Announces Patent Infringement Lawsuit Against Barr Laboratories

  12/31/2007

• Barr Laboratories Will Host Calendar 2007 Third Quarter Earnings Conference Call on November 8, 2007

  10/5/2007

• Warner Chilcott Files Lawsuit Against Barr Laboratories for Infringement of FEMCON FE Patent

  9/24/2007

• Barr Pharmaceuticals, Inc. Confirms Filing an Application With a Paragraph IV Certification for Femcon(R) FE Chewable Oral Contraceptive Product

  8/15/2007

• Barr Laboratories Receives Approval for Generic VESANOID(R) Capsules, 10 mg

  6/22/2007

• Barr Laboratories Announces Withdrawal of ZYPREXA(R) Zydis(R) Patent Litigation

  6/11/2007

• Barr Laboratories and Eli Lilly and Company Voluntarily Dismiss Patent Litigation on Prozac(R) Weekly(TM)

  6/4/2007

• Barr Laboratories Confirms Decision in Azithromycin Inventorship Suit

  6/1/2007

• Barr Laboratories Receives Tentative Approval for a Generic Version of Razadyne(R) Tablets, 4mg, 8mg and 12mg

  5/11/2007

• Barr Laboratories Receives Approval for Generic Nimotop(R) Capsules, 30 mg

  5/2/2007